Male study dosing
0.3–4.5 mgShared trial protocol; not sex-specific
MGMT RESEARCHPRODUCT CONCEPT
RESEARCH COMPOUND
CAGRERA Cagrilintide 5 mg
A long-acting, non-selective amylin receptor agonist for metabolic and receptor-signaling research.
Pricing coming soonNew research material · 5 / 10 mg
This product is being prepared for release. Pricing and availability will be confirmed before ordering opens.
Every compound vial includes one FREE 3 mL BAC Water and one compound / BAC pair holder. Any strength. No minimum purchase. Bundles count their included water toward this offer. Extra BAC Water is $10.00 CAD each.
Prices in CAD before tax. E-transfer accepted · Credit cards coming soon.
Includes FREE 3 mL BAC Water + a compound / BAC pair holder with every vial.
FORMATLyophilized powder
VIAL AMOUNT5 mg
INTENDED USELaboratory research
Female study dosing
0.3–4.5 mgShared trial protocol; not sex-specific
Frequency in trials
Once weeklySelected cited trial only
Route in trials
SubcutaneousInvestigational study material
Reported half-life
Not assigned hereNo verified value assigned to this material
Post-cycle PCT
Not establishedNo validated PCT protocol is provided
Study-reference information only. Any amounts, schedules, routes, or pharmacokinetic values describe the cited study material, not directions for using MGMT Research vials. Male and female labels do not imply separate recommendations. Target or maintenance study arms are not starting-dose instructions.
RESEARCH DESCRIPTION
CAGRERA · Published research
Published clinical studies & evidence limits
A randomized phase 2 study investigated the underlying molecule in adults with overweight or obesity. Using the trial-product estimand, mean weight reductions at 26 weeks ranged from 6.0% to 10.8% across active groups, versus 3.0% with placebo. Gastrointestinal events and injection-site reactions were reported. This selected trial concerns defined study material and protocols, not verified effects or suitability of CAGRERA vials.
Molecular structure
CAGRERA is a synthetic lipidated amylin analogue with sequence substitutions and an N-terminal loop stabilized by a disulfide linkage.
Historical development
Discovery research published in 2021 described molecular modifications addressing receptor activity, aggregation, and protein association.
Laboratory research applications
Laboratory applications include amylin and calcitonin receptor assays, cyclic AMP measurements, peptide conformation studies, aggregation analysis, and chromatographic characterization.
Published findings describe the material and protocols used by the investigators. MGMT Research does not claim equivalent results for its products and does not recommend their use in humans or animals.
For laboratory research use only. Not for human or animal consumption, treatment, diagnosis, or prevention of disease.
Product specifications & handling +
- Product
- CAGRERA · Cagrilintide
- Selected quantity
- 5 mg
- Form
- Lyophilized powder
- Receptors
- Amylin receptors (AMY1R · AMY2R · AMY3R) · calcitonin receptor (CTR)
- Testing
- COA pending · laboratory not assigned
- Origin / dispatch
- Origin not confirmed / Toronto
Batch / lot: Not assigned.
Follow batch-specific supplier instructions and your laboratory’s validated storage and reconstitution procedures. A prepared solution’s shelf life has not been established for this product.
In-stock items usually ship the same day when payment is received before 12:00 p.m. EST. Some larger and wholesale orders ship the following day. Coming-soon products are not available for dispatch.
COA pending. Purity and net-content results will be published when the batch-specific report is available.
MIX EASYYour mixture.
Your mixture.
Made clear.
Select your compound, vial amount, diluent volume, and sample amount. Our calculator converts your inputs into a concentration, volume, and U-100 syringe marking.
01
Set your mixture
mg
mL
Enter an example amount to calculate its volume.
02
Your measurement
CAGRERA
20units
0.2 mL of solution per sample
U-100 scale1 mL = 100 units
Concentration10 mg/mL
Full samples per vial5
THE CALCULATION
2 mg ÷ 10 mg/mL = 0.2 mL
How to read this calculator +
Concentration = vial amount ÷ solution volume. Sample volume = sample amount ÷ concentration. U-100 scale units = volume in mL × 100; these are volume markings, not units of compound potency.
This example assumes the final solution volume equals the diluent volume entered, and that the compound dissolves completely. It does not establish solubility, compatibility, stability, or an administration dose.
Decimal measurements are mathematical results and may fall between markings. Full samples are rounded down; they do not account for handling losses.
The calculator checks concentration mathematics. It does not select a treatment dose or establish compatibility, sterility, or stability. BAC Water is the diluent, not a peptide.